RFK Jr and TRT: separating 'jacked at 70' from clinical fact

What did @athleanx_official actually say?

The creator drew a sharp line between two different uses of testosterone: replacing a deficiency versus using it to push levels above what aging would naturally leave you with. He quoted RFK Jr claiming to be on an "anti-aging protocol" that includes testosterone replacement but "not anabolic steroids," then pushed back on that framing, pointing out that testosterone is itself anabolic. He also noted that many men today pursue TRT without a clinical deficit, using it to "amplify their physiques."

He stopped short of accusing RFK Jr of anything, but the implication was clear: calling testosterone "not a steroid" is a semantic dodge. The creator deserves credit for naming that distinction directly rather than letting the talking point slide. This is actually one of the more honest framings of TRT you'll see in a short-form fitness video.

Does the science back this up?

Yes, and quite firmly. Testosterone is the reference compound against which all anabolic-androgenic steroids are measured. The claim that it is not "anabolic" because you are calling it a replacement therapy is not a scientific distinction, it is a marketing one.

Research consistently shows that exogenous testosterone increases lean mass and strength even in men with low-normal baseline levels. Bhasin et al. (2001, New England Journal of Medicine) demonstrated dose-dependent increases in muscle size and strength across a wide range of testosterone doses in healthy men, including those whose baseline levels were not clinically deficient. The anabolic effects did not require a pathological starting point. More recently, Huang et al. (2021, JAMA Network Open) found that testosterone prescribing has expanded well beyond traditionally hypogonadal populations, with many treated men having borderline or age-related low-normal levels rather than diagnosable hypogonadism. The creator's observation about men "rushing to TRT" without a true deficit is backed by prescribing trend data.

What did they get wrong (or right)?

The creator got the core biochemistry right: testosterone is anabolic regardless of the label attached to the protocol. That part holds up.

Where he is on thinner ice is the implied assumption that "anti-aging" testosterone use necessarily means supraphysiological dosing. It does not always. Some men on physician-supervised TRT are genuinely hypogonadal by any clinical standard (total testosterone below 300 ng/dL with symptoms), and restoring them to a mid-normal range is not the same as using testosterone as a performance drug. The creator acknowledged he was not certain about RFK Jr's actual levels, which was the right caveat to include. But the broader narrative he constructed, that anti-aging framing usually means boosting above normal, is plausible but not universally true. Without lab values, the specific case is unverifiable.

He also got the semantic point exactly right: saying "I don't take anabolic steroids" while using testosterone is like saying "I don't drink alcohol, just whiskey." Testosterone is the parent compound of the anabolic steroid class.

What should you actually know?

If you are considering TRT, the difference between replacement and optimization is not just philosophical, it has real health implications. Genuine hypogonadism (low testosterone with documented symptoms) has a reasonable evidence base for treatment. Using testosterone to push levels above your natural age-appropriate range, what some clinics call "optimization," carries risks that are not fully characterized in long-term studies.

The Testosterone Trials (Snyder et al., 2016, New England Journal of Medicine) showed modest benefits in older men with confirmed low levels, including improved sexual function and some bone density benefits, but the cardiovascular risk picture remained mixed. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine) found no significant increase in major cardiovascular events in men with hypogonadism and existing cardiovascular risk, but that population had documented deficiency. Applying those findings to men without clinical hypogonadism is a stretch.

The bottom line: the label on a protocol does not change the pharmacology. Testosterone is anabolic whether your doctor calls it replacement, optimization, or an anti-aging protocol. Anyone telling you otherwise is doing word games, not medicine.